Upload Image (Max 20MB per Image)
Mapi Pharma, developer of complex bulk Active Pharmaceutical Ingredients (APIs), has been granted a US patent for a long acting depot formulation of glatiramer acetate, which is under the development as a once-a-month treatment for Multiple ...
Tags: Mapi Pharma, Multiple Sclerosis Treatment